Aptuit LLC has appointed two new members to its executive leadership team. Kurt Dinkelacker has been named executive vice president and chief financial officer and Kevin Duffield has been promoted to vice president, sales and business development.
Mr. Dinkelacker reports to Stuart Needleman, Aptuit’s president and chief operating officer. Mr. Dinkelacker has extensive experience in managing global financial operations in growth-focused corporations. Previously, he was executive vice president and chief financial officer at Retrievex. He also held leadership positions at Financing Alternatives, TeleSpectrum Worldwide and IKON Office Solutions.
Mr. Duffield takes on new responsibilities handling global sales and marketing, also reporting to Mr. Needleman. Mr. Duffield has more than 25 years of experience in pharmaceutical contract manufacturing services. He has held several leadership positions in sales, business development, and operations of cGMP development and manufacturing facilities.
Mr. Needleman said, “We congratulate these professionals and look forward to their contributions to our Executive Leadership team. We’ve put a great deal of effort in finding the people who represent our ‘uncommon expertise’ across a range of disciplines. These two proven pros are valuable additions to our team, ready to implement a strategy that will help steer Aptuit to its position as a market-leading provider of early to mid-phase integrated drug discovery and development.”